Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Acutaas Chemicals: CDMO business outlook improves

    The CDMO business appears steady and additional approvals of indications for the oncology drug – Darolutamide – add to revenue visibility. Further, another key contract is expected to commence from Q4 FY26

    Anubhav Sahu
    August 05, 2025 / 09:30 IST
    New CDMO contract expected to commence from Q4FY26
    • PRO Panorama

      Moneycontrol Pro Panorama | War wounds cut deeper

      Mar 30, 2026 / 03:09 PM IST

      In this edition of Moneycontrol Pro Panorama: Fed futures price prolonged Iran conflict risks; RBI move curbs forex arbitrage, rai...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender | The Middle-East burns; the world pays

      Mar 21, 2026 / 10:00 AM IST

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More